A
Archana Hinduja
Researcher at Ohio State University
Publications - 58
Citations - 657
Archana Hinduja is an academic researcher from Ohio State University. The author has contributed to research in topics: Stroke & Internal medicine. The author has an hindex of 12, co-authored 49 publications receiving 468 citations. Previous affiliations of Archana Hinduja include University of Arkansas for Medical Sciences & Cleveland Clinic.
Papers
More filters
Journal ArticleDOI
Final Results of the RHAPSODY Trial: A Multi-Center, Phase 2 Trial Using a Continual Reassessment Method to Determine the Safety and Tolerability of 3K3A-APC, A Recombinant Variant of Human Activated Protein C, in Combination with Tissue Plasminogen Activator, Mechanical Thrombectomy or both in Moderate to Severe Acute Ischemic Stroke.
Patrick D. Lyden,Kent E. Pryor,Christopher S. Coffey,Merit Cudkowicz,Robin Conwit,Ashutosh P Jadhav,Robert N. Sawyer,Jan Claassen,Opeolu Adeoye,Shlee S. Song,Peter M Hannon,Natalia S. Rost,Archana Hinduja,Michel T. Torbey,Jin-Moo Lee,Curtis G. Benesch,Michael A. Rippee,Marilyn M Rymer,Michael T. Froehler,E. Clarke Haley,Mark Johnson,Jon W. Yankey,Kim Magee,Julie Qidwai,Howard P. Levy,E. Mark Haacke,Miller Fawaz,Thomas P. Davis,Arthur W. Toga,John H. Griffin,Berislav V. Zlokovic +30 more
TL;DR: The NeuroNEXT trial as mentioned in this paper used a continual reassessment method to determine the maximally tolerated dose (MTD) of 3K3A-APC in ischemic stroke patients.
Journal ArticleDOI
Posterior Reversible Encephalopathy Syndrome: Clinical Features and Outcome.
TL;DR: This review is aimed to summarize the updated knowledge on the typical and atypical clinical and imaging features, prognostic markers and gaps in literature for future research on Posterior reversible encephalopathy syndrome.
Journal ArticleDOI
Rosai-Dorfman disease manifesting as intracranial and intraorbital lesion.
Archana Hinduja,Archana Hinduja,L. Giselle Aguilar,L. Giselle Aguilar,Thomas Steineke,David Nochlin,Joseph Landolfi +6 more
TL;DR: A 42-year-old male presented with painless, progressive left visual loss of 4 months duration and underwent radiation therapy with significant improvement of his symptoms, and inflammatory infiltrate in the absence of an infectious agent, emperipolesis and a positive S100 stain was consistent with Rosai-Dorfman disease.
Journal ArticleDOI
Hematoma expansion in spontaneous intracerebral hemorrhage: predictors and outcome.
TL;DR: Patients with prior Warfarin use and IVHs are at risk of hematoma expansion and Aggressive measures to prevent hematomas growth are important in these patients.
Journal ArticleDOI
Predictors of Poor Outcome in Patients with Posterior Reversible Encephalopathy Syndrome
TL;DR: Large prospective studies incorporating serial blood glucose values and advanced imaging studies are required to validate the findings of this retrospective review of patients with Posterior reversible encephalopathy syndrome.